Ethical Issues in Fecal Microbiota Transplantation in Practice (Q40242658)

18 September 2017

Ethical Issues in Fecal Microbiota Transplantation in Practice (English)

1 reference

18 September 2017

0 references

1 reference

Yonghui Ma

1

0 references

author name string

Jiayu Liu

2

1 reference

18 September 2017

Catherine Rhodes

3

1 reference

18 September 2017

Yongzhan Nie

4

1 reference

18 September 2017

Faming Zhang

5

1 reference

18 September 2017

1 May 2017

1 reference

American Journal of Bioethics

18 September 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 September 2017

17

1 reference

18 September 2017

5

1 reference

18 September 2017

34-45

1 reference

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

18 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Gut microbiota and non-alcoholic fatty liver disease: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Treating Clostridium difficile infection with fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal microbiota transplantation: techniques, applications, and issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Treatment of ulcerative colitis using fecal bacteriotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal Microbiota Transplant: Respice, Adspice, Prospice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The nature of suffering and the goals of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The interplay between the intestinal microbiota and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Step-up Fecal Microbiota Transplantation (FMT) Strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Collective unconscious: how gut microbes shape human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

If microbial ecosystem therapy can change your life, what's the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The gut microbiome: the role of a virtual organ in the endocrinology of the host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Gastrointestinal microflora studies in late-onset autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Identifying personal microbiomes using metagenomic codes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Unraveling the influence of gut microbes on the mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

"Who owns your poop?": insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The doctor-patient relationship, defensive medicine and overprescription in Chinese public hospitals: evidence from a cross-sectional survey in Shenzhen city

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Patient perceptions of fecal microbiota transplantation for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Optimal screening and donor management in a public stool bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Depression and anxiety in people with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Ethical, legal, and social considerations in conducting the Human Microbiome Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Donor Recruitment for Fecal Microbiota Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The impact of gut microbes in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Ensuring the safe and effective FDA regulation of fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The yuck factor: when disgust meets discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Gut microbiota in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Policy: How to regulate faecal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Infection control in the multidrug-resistant era: tending the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Functional interactions between the gut microbiota and host metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Cost Averted With Timely Fecal Microbiota Transplantation in the Management of Recurrent Clostridium difficile Infection in Alberta, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

The Human Microbiome and Public Health: Social and Ethical Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15265161.2017.1299240

10.1080/15265161.2017.1299240

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference